Influenza virus vaccine quadrivalent - Il Yang

Drug Profile

Influenza virus vaccine quadrivalent - Il Yang

Alternative Names: IL-YANG Flu Vaccine QIV; IL-YANG Flu Vaccine Quadrivalent Inj

Latest Information Update: 14 Feb 2017

Price : $50

At a glance

  • Originator Il-Yang
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Influenza virus infections

Most Recent Events

  • 01 Oct 2015 Phase-III clinical trials in Influenza virus infections (Prevention) in South Korea (IM) (NCT02677493)
  • 01 Jul 2015 Phase-I/II clinical trials in Influenza virus infections (Prevention) in South Korea (IM)
  • 01 Jul 2015 Il Pharma completes a phase I/IIa trial in Influenza virus infections (Prevention) in South Korea (NCT02480998)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top